Association of retroperitoneal fibrosis with malignancy and its outcomes

Abstract Introduction Retroperitoneal fibrosis (RPF) is characterized by a highly fibrotic retroperitoneal mass and encompasses the idiopathic form and secondary to malignancies. Because we have limited knowledge whether RPF is associated with malignancy, we aimed to investigate the relationship bet...

Full description

Bibliographic Details
Main Authors: Sang Jin Lee, Jung Su Eun, Min Jung Kim, Yeong Wook Song, Young Mo Kang
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Arthritis Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13075-021-02627-3
_version_ 1818731075517546496
author Sang Jin Lee
Jung Su Eun
Min Jung Kim
Yeong Wook Song
Young Mo Kang
author_facet Sang Jin Lee
Jung Su Eun
Min Jung Kim
Yeong Wook Song
Young Mo Kang
author_sort Sang Jin Lee
collection DOAJ
description Abstract Introduction Retroperitoneal fibrosis (RPF) is characterized by a highly fibrotic retroperitoneal mass and encompasses the idiopathic form and secondary to malignancies. Because we have limited knowledge whether RPF is associated with malignancy, we aimed to investigate the relationship between RPF and malignancy and to compare the characteristics and prognosis of cancers among patients with RPF. Methods Medical records of 111 patients diagnosed as having RPF were reviewed and 38 cases of cancer, confirmed by biopsy, were identified. Standardized incidence ratios (SIRs) were calculated for cancers and stratified according to cancer type and RPF-cancer diagnosis interval. Cancer characteristics and outcomes were compared between RPF-cancer diagnosis intervals. Results The average age at RPF diagnosis was 59.2 ± 15.0 years, and 69.4% of the patients were male. The cancer SIRs in patients with RPF relative to age- and sex-matched individuals in the general population was 2.2 (1.6–3.1). SIRs of renal pelvis cancer and multiple myeloma were significantly higher than in the general population. When stratified by RPF-cancer intervals, the SIR for cancer was 9.9 within 1 year of RPF diagnosis, while no significant increase in the SIR was found after 1 year from RPF diagnosis. Cancer stage was more advanced at the time of diagnosis in patients within a 1-year interval for RPF than those with cancer within a >5-year interval, with a correspondingly increased mortality in the former patients. Conclusions RPF was significantly associated with malignancy, particularly those diagnosed within 1 year of RPF diagnosis. Cancer stages at diagnosis were more advanced and the mortality rate was higher in patients within a 1-year interval between RPF and cancer diagnosis than in those with a >5-year interval between diagnoses.
first_indexed 2024-12-17T23:11:55Z
format Article
id doaj.art-eeb3e25318cc4d499007e2aeacbf5db2
institution Directory Open Access Journal
issn 1478-6362
language English
last_indexed 2024-12-17T23:11:55Z
publishDate 2021-09-01
publisher BMC
record_format Article
series Arthritis Research & Therapy
spelling doaj.art-eeb3e25318cc4d499007e2aeacbf5db22022-12-21T21:29:07ZengBMCArthritis Research & Therapy1478-63622021-09-012311910.1186/s13075-021-02627-3Association of retroperitoneal fibrosis with malignancy and its outcomesSang Jin Lee0Jung Su Eun1Min Jung Kim2Yeong Wook Song3Young Mo Kang4Division of Rheumatology, School of Medicine, Kyungpook National UniversityDivision of Rheumatology, School of Medicine, Kyungpook National UniversityDivision of Rheumatology, College of Medicine, Seoul National UniversityDepartment of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine, Medical Research Institute, Seoul National UniversityDivision of Rheumatology, School of Medicine, Kyungpook National UniversityAbstract Introduction Retroperitoneal fibrosis (RPF) is characterized by a highly fibrotic retroperitoneal mass and encompasses the idiopathic form and secondary to malignancies. Because we have limited knowledge whether RPF is associated with malignancy, we aimed to investigate the relationship between RPF and malignancy and to compare the characteristics and prognosis of cancers among patients with RPF. Methods Medical records of 111 patients diagnosed as having RPF were reviewed and 38 cases of cancer, confirmed by biopsy, were identified. Standardized incidence ratios (SIRs) were calculated for cancers and stratified according to cancer type and RPF-cancer diagnosis interval. Cancer characteristics and outcomes were compared between RPF-cancer diagnosis intervals. Results The average age at RPF diagnosis was 59.2 ± 15.0 years, and 69.4% of the patients were male. The cancer SIRs in patients with RPF relative to age- and sex-matched individuals in the general population was 2.2 (1.6–3.1). SIRs of renal pelvis cancer and multiple myeloma were significantly higher than in the general population. When stratified by RPF-cancer intervals, the SIR for cancer was 9.9 within 1 year of RPF diagnosis, while no significant increase in the SIR was found after 1 year from RPF diagnosis. Cancer stage was more advanced at the time of diagnosis in patients within a 1-year interval for RPF than those with cancer within a >5-year interval, with a correspondingly increased mortality in the former patients. Conclusions RPF was significantly associated with malignancy, particularly those diagnosed within 1 year of RPF diagnosis. Cancer stages at diagnosis were more advanced and the mortality rate was higher in patients within a 1-year interval between RPF and cancer diagnosis than in those with a >5-year interval between diagnoses.https://doi.org/10.1186/s13075-021-02627-3Retroperitoneal fibrosisMalignancyStandardized incidence ratiosSurvival
spellingShingle Sang Jin Lee
Jung Su Eun
Min Jung Kim
Yeong Wook Song
Young Mo Kang
Association of retroperitoneal fibrosis with malignancy and its outcomes
Arthritis Research & Therapy
Retroperitoneal fibrosis
Malignancy
Standardized incidence ratios
Survival
title Association of retroperitoneal fibrosis with malignancy and its outcomes
title_full Association of retroperitoneal fibrosis with malignancy and its outcomes
title_fullStr Association of retroperitoneal fibrosis with malignancy and its outcomes
title_full_unstemmed Association of retroperitoneal fibrosis with malignancy and its outcomes
title_short Association of retroperitoneal fibrosis with malignancy and its outcomes
title_sort association of retroperitoneal fibrosis with malignancy and its outcomes
topic Retroperitoneal fibrosis
Malignancy
Standardized incidence ratios
Survival
url https://doi.org/10.1186/s13075-021-02627-3
work_keys_str_mv AT sangjinlee associationofretroperitonealfibrosiswithmalignancyanditsoutcomes
AT jungsueun associationofretroperitonealfibrosiswithmalignancyanditsoutcomes
AT minjungkim associationofretroperitonealfibrosiswithmalignancyanditsoutcomes
AT yeongwooksong associationofretroperitonealfibrosiswithmalignancyanditsoutcomes
AT youngmokang associationofretroperitonealfibrosiswithmalignancyanditsoutcomes